![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, June 15, 2009 1:01:53 PM
"Peter’s overall expertise and clinical background in Nuclear Medicine will significantly enhance our management team and bottom line," said John Zehner, COO and VP of Sales. "I have known Peter for the past decade, his understanding of the industry, clinical knowledge and his ability to always be ahead of the curve has made him a tremendous addition to our team. Peter has the proven ability to assist both our customers and companies in all facets of their patient care, business development and revenue growth.”
Most recently, Mr. Webner served as Vice President Product Development for IBA North America – Ion Beam Applications is a global provider of healthcare solutions with PET and SPECT applications. During his nine year tenure at IBA, he launched the North East market and had significant impact on increasing revenue, margins and earnings. He led initiatives to increase new product development efforts, such as, a mobile Rb-82 generator sharing plan for Cardiac imaging and was extensively involved in product acquisitions for IBA.
“This is an incredible opportunity to expand my career in Nuclear Medicine. Positron has an outstanding line of products,” stated Peter Webner. “The recently approved 510k Attrius PET scanner, the Pulse® SPECT scanner, the new Tech-Assist™, and the new Nuclear Pharm-Assist® provide imaging and automation solutions. The entire product line utilizes state of the art technology to deliver practical, safe, and cost effective care and work flow solutions to our industry for both Cardiac and Oncology applications.”
Mr. Webner currently serves on the Society of Nuclear Medicine’s PET Utilization Task force, Reimbursement Committee, and APC Task force. He also serves on the Academy of Molecular Imaging’s Referring Physician Education Workgroup, Reimbursement, and Health Economics Workgroup.
About Positron
Positron is a molecular imaging company with a focus on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging to radiopharmaceutical distribution. Positron has four primary products: the Attrius™, a PET imaging device; the Pulse®, a SPECT imaging device; the Nuclear Pharm-Assist®, an automated radiopharmaceutical distribution device; and the Tech-Assist™, a radiopharmaceutical patient injection shield. Over 150 Positron products are installed in hospitals and medical offices around the world. More information about Positron is available at www.positron.com.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM